Organigram's Aurora Bid Deals Blow to Hostile Curaleaf Bid -- Market Talk

1121 ET - Organigram's roughly C$561 million offer for Canadian cannabis company Aurora Cannabis fends off a hostile bid from rival Curaleaf, marking a new turn in Aurora's buyout saga. At C$7.80 a share, the agreed cash-and-stock deal offers a 21% premium over Curaleaf's unsolicited C$6.45 bid and a 93% premium over Aurora's unaffected price in August. The transaction is backed by a GBP100 million commitment from British American Tobacco and a C$210 million credit facility. Organigram touts the combination as supporting critical scale across major Canadian and European markets. Meanwhile, Aurora said the deal provides an immediate valuation benefit while blocking a disruptive takeover battle that has played out since August. Aurora shares rise 20% to C$7.08. (adriano.marchese@wsj.com)

(END) Dow Jones Newswires

November 03, 2026 11:21 ET (16:21 GMT)